As a pathogenic bacterium frequently contains both TLR2 agonist[11], our results indicated that breast cancer invasiveness and adhesiveness would be enhanced after the stimulation by peptidoglycan in bacteria and the highly metastatic breast cancer cells are more sensitive to pathogenic bacterial peptidoglycan than poorly metastatic breast cancer cells. The gene discussed is TLR2; the disease is breast carcinoma.